{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:38:39Z","timestamp":1793306319490,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2016,10,21]]},"abstract":"<jats:p>Acetaminophen (APAP) overdoses are of major clinical concern. Growing evidence underlines a pathogenic contribution of sterile postinjury inflammation in APAP\u2010induced acute liver injury (APAP\u2010ALI) and justifies development of anti\u2010inflammatory therapies with therapeutic efficacy beyond the therapeutic window of the only current treatment option, <jats:italic toggle=\"yes\">N<\/jats:italic>\u2010acetylcysteine (NAC). The inflammatory mediator, high mobility group box 1 (HMGB1), is a key regulator of a range of liver injury conditions and is elevated in clinical and preclinical APAP\u2010ALI. The anti\u2010HMGB1 antibody (m2G7) is therapeutically beneficial in multiple inflammatory conditions, and anti\u2010HMGB1 polyclonal antibody treatment improves survival in a model of APAP\u2010ALI. Herein, we developed and investigated the therapeutic efficacy of a partly humanized anti\u2010HMGB1 monoclonal antibody (mAb; h2G7) and identified its mechanism of action in preclinical APAP\u2010ALI. The mouse anti\u2010HMGB1 mAb (m2G7) was partly humanized (h2G7) by merging variable domains of m2G7 with human antibody\u2010Fc backbones. Effector function\u2010deficient variants of h2G7 were assessed in comparison with h2G7 <jats:italic toggle=\"yes\">in vitro<\/jats:italic> and in preclinical APAP\u2010ALI. h2G7 retained identical antigen specificity and comparable affinity as m2G7. 2G7 treatments significantly attenuated APAP\u2010induced serum elevations of alanine aminotransferase and microRNA\u2010122 and completely abrogated markers of APAP\u2010induced inflammation (tumor necrosis factor, monocyte chemoattractant protein 1, and chemokine [C\u2010X\u2010C motif] ligand 1) with prolonged therapeutic efficacy as compared to NAC. Removal of complement and\/or Fc receptor binding did not affect h2G7 efficacy. <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> This is the first report describing the generation of a partly humanized HMGB1\u2010neutralizing antibody with validated therapeutic efficacy and with a prolonged therapeutic window, as compared to NAC, in APAP\u2010ALI. The therapeutic effect was mediated by HMGB1 neutralization and attenuation of postinjury inflammation. These results represent important progress toward clinical implementation of HMGB1\u2010specific therapy as a means to treat APAP\u2010ALI and other inflammatory conditions. (H<jats:sc>epatology<\/jats:sc> 2016;64:1699\u20101710).<\/jats:p>","DOI":"10.1002\/hep.28736","type":"journal-article","created":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T10:58:21Z","timestamp":1472727501000},"page":"1699-1710","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":100,"title":["A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug\u2010induced liver injury and postinjury inflammation in mice"],"prefix":"10.1097","volume":"64","author":[{"given":"Peter","family":"Lundb\u00e4ck","sequence":"first","affiliation":[{"name":"Department of Medicine, Rheumatology Unit,Karolinska Institute,Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Lea","sequence":"additional","affiliation":[{"name":"MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology,Liverpool University,Liverpool,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Sowinska","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rheumatology Unit,Karolinska Institute,Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ottosson","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health,Karolinska Institute,Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Melin","family":"F\u00fcrst","sequence":"additional","affiliation":[{"name":"Section of Medical Protein Chemistry, Department of Translational Medicine,Lund University,Malm\u00f6,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Steen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rheumatology Unit,Karolinska Institute,Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Aulin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rheumatology Unit,Karolinska Institute,Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna I.","family":"Clarke","sequence":"additional","affiliation":[{"name":"MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology,Liverpool University,Liverpool,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Kipar","sequence":"additional","affiliation":[{"name":"MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology,Liverpool University,Liverpool,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Klevenvall","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health,Karolinska Institute,Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[{"name":"Laboratory of Biomedical Science,The Feinstein Institute for Medical Research,Manhasset,NY,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Palmblad","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health,Karolinska Institute,Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Kevin","family":"Park","sequence":"additional","affiliation":[{"name":"MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology,Liverpool University,Liverpool,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Tracey","sequence":"additional","affiliation":[{"name":"Laboratory of Biomedical Science,The Feinstein Institute for Medical Research,Manhasset,NY,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Blom","sequence":"additional","affiliation":[{"name":"Section of Medical Protein Chemistry, Department of Translational Medicine,Lund University,Malm\u00f6,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health,Karolinska Institute,Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Antoine","sequence":"additional","affiliation":[{"name":"MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology,Liverpool University,Liverpool,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Erlandsson Harris","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rheumatology Unit,Karolinska Institute,Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"issue":"Suppl 1","key":"hep28736-bib-0001-20241017","first-page":"S1","article-title":"The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the future","volume":"37","year":"2014","journal-title":"Drug Saf"},{"key":"hep28736-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jhep.2011.12.019","article-title":"Molecular forms of HMGB1 and keratin\u201018 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"hep28736-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","year":"2002","journal-title":"Ann Intern Med"},{"key":"hep28736-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/hep.25657","article-title":"Source and characterization of hepatic macrophages in acetaminophen\u2010induced acute liver failure in humans","volume":"56","year":"2012","journal-title":"Hepatology"},{"key":"hep28736-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","year":"2012","journal-title":"J Exp Med"},{"key":"hep28736-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2119\/molmed.2011.00389","article-title":"Redox modification of cysteine residues regulates the cytokine activity of high mobility group box\u20101 (HMGB1)","volume":"18","year":"2012","journal-title":"Mol Med"},{"key":"hep28736-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1084\/jem.20141318","article-title":"MD\u20102 is required for disulfide HMGB1\u2010dependent TLR4 signaling","volume":"212","year":"2015","journal-title":"J Exp Med"},{"key":"hep28736-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","article-title":"HMGB1 in health and disease","volume":"40","year":"2014","journal-title":"Mol Aspects Med"},{"key":"hep28736-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","article-title":"Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion","volume":"22","year":"2003","journal-title":"EMBO J"},{"key":"hep28736-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.26294","article-title":"Mechanistic biomarkers provide early and sensitive detection of acetaminophen\u2010induced acute liver injury at first presentation to hospital","volume":"58","year":"2013","journal-title":"Hepatology"},{"key":"hep28736-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/lt.23958","article-title":"Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia\/reperfusion injury in mice","volume":"20","year":"2014","journal-title":"Liver Transpl"},{"key":"hep28736-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"22672","DOI":"10.1074\/jbc.M114.552141","article-title":"High mobility group box\u20101 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD)","volume":"289","year":"2014","journal-title":"J Biol Chem"},{"key":"hep28736-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","article-title":"Bile acid\u2010induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis","volume":"283","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"hep28736-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI76887","article-title":"The HMGB1\/RAGE axis triggers neutrophil\u2010mediated injury amplification following necrosis","volume":"125","year":"2015","journal-title":"J Clin Invest"},{"key":"hep28736-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2119\/molmed.2010.00126","article-title":"Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity","volume":"16","year":"2010","journal-title":"Mol Med"},{"key":"hep28736-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection","volume":"29","year":"2011","journal-title":"Ann Rev Immunol"},{"key":"hep28736-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG\u20101 as a late mediator of endotoxin lethality in mice","volume":"285","year":"1999","journal-title":"Science"},{"key":"hep28736-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/art.11161","article-title":"Successful treatment of collagen\u2010induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity","volume":"48","year":"2003","journal-title":"Arthritis Rheum"},{"key":"hep28736-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biologicals.2015.06.009","article-title":"Immunogenicity assessment of monoclonal antibody products: a simulated case study correlating antibody induction with clinical outcomes","volume":"43","year":"2015","journal-title":"Biologicals"},{"key":"hep28736-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20121486","article-title":"Monoclonal IgG antibodies generated from joint\u2010derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition","volume":"210","year":"2013","journal-title":"J Exp Med"},{"key":"hep28736-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT\u2010PCR and expression vector cloning","volume":"329","year":"2008","journal-title":"J Immunol Methods"},{"key":"hep28736-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.20052203","article-title":"Role of HMGB1 in apoptosis\u2010mediated sepsis lethality","volume":"203","year":"2006","journal-title":"J Exp Med"},{"key":"hep28736-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.4049\/jimmunol.169.3.1379","article-title":"Isotype can affect the fine specificity of an antibody for a polysaccharide antigen","volume":"169","year":"2002","journal-title":"J Immunol"},{"key":"hep28736-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","year":"2002","journal-title":"Nature"},{"key":"hep28736-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-230X-14-66","article-title":"HMGB1 neutralization is associated with bacterial translocation during acetaminophen hepatotoxicity","volume":"14","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"hep28736-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/toxsci\/54.2.509","article-title":"The hepatic inflammatory response after acetaminophen overdose: role of neutrophils","volume":"54","year":"2000","journal-title":"Toxicol Sci"},{"key":"hep28736-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2011.02501.x","article-title":"Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"hep28736-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-3083.2008.02194.x","article-title":"Protective effect of antagonist of high\u2010mobility group box 1 on lipopolysaccharide\u2010induced acute lung injury in mice","volume":"69","year":"2009","journal-title":"Scand J Immunol"},{"key":"hep28736-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1073\/pnas.2434651100","article-title":"Reversing established sepsis with antagonists of endogenous high\u2010mobility group box 1","volume":"101","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"hep28736-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/332738a0","article-title":"The binding site for C1q on IgG","volume":"332","year":"1988","journal-title":"Nature"},{"key":"hep28736-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/eji.200737581","article-title":"Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis","volume":"37","year":"2007","journal-title":"Eur J Immunol"},{"key":"hep28736-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1182\/blood-2009-08-239020","article-title":"The IgG\u2010specific endoglycosidase EndoS inhibits both cellular and complement\u2010mediated autoimmune hemolysis","volume":"115","year":"2010","journal-title":"Blood"},{"key":"hep28736-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1053\/j.gastro.2015.08.053","article-title":"CSF1 restores innate immunity after liver injury in mice and serum levels indicate outcomes of patients with acute liver failure","volume":"149","year":"2015","journal-title":"Gastroenterology"},{"key":"hep28736-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.2741\/1456","article-title":"B cell\/antibody tolerance to our own antigens","volume":"9","year":"2004","journal-title":"Front Biosci"},{"key":"hep28736-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20042614","article-title":"The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia\u2010reperfusion","volume":"201","year":"2005","journal-title":"J Exp Med"},{"key":"hep28736-bib-0036-20241017","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1096\/fj.07-8770com","article-title":"Anti\u2010high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats","volume":"21","year":"2007","journal-title":"FASEB J"},{"key":"hep28736-bib-0037-20241017","first-page":"257930","article-title":"Anti\u2010HMGB1 neutralizing antibody ameliorates neutrophilic airway inflammation by suppressing dendritic cell\u2010mediated Th17 polarization","volume":"2014","year":"2014","journal-title":"Mediators Inflamm"},{"key":"hep28736-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.20120189","article-title":"Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release","volume":"209","year":"2012","journal-title":"J Exp Med"},{"key":"hep28736-bib-0039-20241017","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1073\/pnas.1003893107","article-title":"A critical cysteine is required for HMGB1 binding to Toll\u2010like receptor 4 and activation of macrophage cytokine release","volume":"107","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"hep28736-bib-0040-20241017","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.4049\/jimmunol.164.8.4178","article-title":"Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc","volume":"164","year":"2000","journal-title":"J Immunol"},{"key":"hep28736-bib-0041-20241017","first-page":"209","article-title":"IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis","volume":"9","year":"2012","journal-title":"J Neuroinflammation"},{"key":"hep28736-bib-0042-20241017","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1073\/pnas.80.21.6632","article-title":"Biological significance of carbohydrate chains on monoclonal antibodies","volume":"80","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"hep28736-bib-0043-20241017","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/db11-1578","article-title":"A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control","volume":"61","year":"2012","journal-title":"Diabetes"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28736","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28736","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201611000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T01:01:20Z","timestamp":1729213280000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201611000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.28736","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]},"assertion":[{"value":"2015-11-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}